|
|
||||||||
The Journal of Immunology, Vol 147, Issue 8 2643-2651, Copyright © 1991 by American Association of Immunologists
ARTICLES |
N Koch, G Moldenhauer, WJ Hofmann and P Moller
Institute of Immunology and Genetics, German Cancer Research Center, Heidelberg.
In previous investigations, it had been shown that class II and associated invariant polypeptides are sorted to an endocytic route where transport is delayed. Invariant chain (Ii) is degraded in a post- Golgi compartment, presumably an endosomal vesicle, and only class II molecules emerge on the cell surface. By using a mAb against the extracytoplasmic domain of human Ii, we demonstrate, by electron microscopy and by cytofluorometry, surface expression of Ii on lymphoma cells and on human B lymphocytes. We examined surface expression of Ii upon inhibition by brefeldin A of intracellular transport from the endoplasmic reticulum to the Golgi stack. This treatment rapidly depletes the cell surface of Ii. In the subsequent absence of brefeldin A, Ii appears rapidly at the cell surface. Within 5 h, the previous level of surface Ii (sIi) is reconstituted. Chloroquine abrogates depletion of sIi by brefeldin A, apparently by inhibition of internalization of sIi. Because on its route to the cell surface Ii is not proteolytically digested, it was possible that Ii and associated class II molecules are not separated on this pathway. Immunochemical studies reveal that on the cell surface of a B lymphoma cell line a proportion of Ii and class II polypeptides are associated.
This article has been cited by other articles:
![]() |
L. Pond and C. Watts Functional Early Endosomes Are Required for Maturation of Major Histocompatibility Complex Class II Molecules in Human B Lymphoblastoid Cells J. Biol. Chem., June 18, 1999; 274(25): 18049 - 18054. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Freeman, A. A. Cardoso, V. A. Boussiotis, A. Anumanthan, R. W. Groves, T. S. Kupper, E. A. Clark, and L. M. Nadler The BB1 Monoclonal Antibody Recognizes Both Cell Surface CD74 (MHC Class II-Associated Invariant Chain) as Well as B7-1 (CD80), Resolving the Question Regarding a Third CD28/CTLA-4 Counterreceptor J. Immunol., September 15, 1998; 161(6): 2708 - 2715. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Roucard, F. Garban, N. A. Mooney, D. J. Charron, and M. L. Ericson Conformation of Human Leukocyte Antigen Class II Molecules. EVIDENCE FOR SUPERDIMERS AND EMPTY MOLECULES ON HUMAN ANTIGEN PRESENTING CELLS J. Biol. Chem., June 14, 1996; 271(24): 13993 - 14000. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neumann, N. Schach, and N. Koch Glycosylation Signals That Separate the Trimerization from the MHC Class II-binding Domain Control Intracellular Degradation of Invariant Chain J. Biol. Chem., April 13, 2001; 276(16): 13469 - 13475. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |